We next asked whether any of the verified CpG sites of ADAM8, PLAU, TNFSF12, ME3 and GSTM1 were differentially methylated in invasive BC patient samples from TCGA database (sample identifiers are provided in Supplementary Table 3). This evidence concerns the gene GSTM1 and breast cancer.